Telo Genomics Corp.: Telo Genomics Completes Processing of Multiple Myeloma Drug Resistance Patient Samples
Toronto, Ontario--(Newsfile Corp. - August 17, 2022) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "TELO") announces the completion of the laboratory processing and analysis of patient